Lexie launches its B3 Powered by Bose OTC hearing aids with longer battery life, Bluetooth streaming, hands-free calling, and automatic sound focus.
✦ Clinical Takeaway ✦
No actionable change for clinical audiologists; the B3 is an OTC device that operates outside the prescription fitting pathway, though awareness is useful for counselling patients who ask about self-fit options.
✦ Why It Matters ✦
The continued growth of Bose-powered OTC hearing aids from Lexie signals intensifying competition in the self-fit segment and may shift how some patients with mild-to-moderate hearing loss first access amplification.
✦ Key Points ✦
- 01Lexie B3 is an OTC hearing aid co-developed with Bose audio technology.
- 02Features include extended battery life, Bluetooth streaming, and hands-free calling.
- 03Automatic sound focus adjusts directional hearing without manual intervention.
- 04No prescription or audiologist fitting required under current OTC regulations.
- 05No peer-reviewed efficacy data accompany this launch announcement.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
The B3 offers extended battery life compared to prior Lexie models.
press releaseunclearAutomatic sound focus improves hearing in noisy environments.
press releasepromotional
